Wikipedia -WSS

Wikipedia

author：entertainment 2025-10-01 23:04:07 - browse：24

Adam's take main illustration — Molly Ferguson/STAT

Novartis said Monday that it intends to buy MorphoSys for just under $3 billion. The deal will not close. Six months from now, or sooner, Novartis will walk away — slightly embarrassed but otherwise unscathed — happy to pay a small breakup fee to MorphoSys to avoid owning a drug for myelofibrosis that regulators turned away.

MorphoSys will not fare as well from the breakup. Its future, and that of the drug called pelabresib at the center of the deal, will be thrown into limbo.

This is all speculation on my part, but it’s supported by separate conversations with two people familiar with pelabresib and the debate inside Novartis over the MorphoSys acquisition. They requested anonymity to discuss confidential matters.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Mass General, Mayo Clinic look to monetize custom

WSS

5 ways to address the shortage of health care workers

Ohio train derailment: Experts on toxic chemical risks

To bolster infectious disease surveillance, genomics powerhouses team up

Doctor of U.S. President Joe Biden says he is fit for duty

Neuroscience renaissance leads to new crop of psychiatric drugs

Maisha Meds is a PBM, but don't call it that

knowledge

Wikipedia

Wikipedia

Cancer drug shortages should be causing more outrage

Update the Apgar Score to remove skin color

Drug repurposing or repositioning? The language matters

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

ChatGPT in medicine: STAT answers readers' burning questions

Update the Apgar Score to remove skin color

In age of alternative facts, a scholarly course on calling out crap

The inclusion problem at the heart of rehabilitation research

hotspot

Elisabeth Bik tackles the widespread issue of research misconduct

FDA sets aggressive timeline for overhauling inspection procedures

Doctor of U.S. President Joe Biden says he is fit for duty

High breast density mammograms need follow

Cholera vaccine supplies dangerously low, outbreaks surging

TikTok, Instagram influencers need more rules for drug ads

focus

hotspot

leisure time

focus